Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: TREM-2 Attenuates Macrophage Activation

Isaiah R. Turnbull, Susan Gilfillan, Marina Cella, Taiki Aoshi, Mark Miller, Laura Piccio, Maristela Hernandez and Marco Colonna
J Immunol September 15, 2006, 177 (6) 3520-3524; DOI: https://doi.org/10.4049/jimmunol.177.6.3520
Isaiah R. Turnbull
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Gilfillan
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marina Cella
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taiki Aoshi
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Miller
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Piccio
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maristela Hernandez
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Colonna
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    TREM-2 is expressed on macrophages. A, Peritoneal macrophages were isolated before (day 1) or after (days 2–4) injection of thioglycollate. Thioglycollate-recruited macrophages express TREM-2. B, Mice were sensitized to OVA by immunization and then challenged intranasally with OVA. Macrophages recruited to the alveolar space in the sensitized mouse express TREM-2. C, The murine macrophage cell line RAW264 express TREM-2, which is down-regulated after overnight activation by IFN-γ or LPS at indicated doses. D, TREM-2 is highly expressed on BMDM from WT mice.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Alternative activation is sufficient but not necessary for TREM-2 expression. A, Resident peritoneal cells were isolated from WT mice and cultured for 48 h in the presence of MCSF with or without IL-4. Culture with IL-4 induced TREM-2 expression of resident peritoneal macrophages. B, Thioglycollate-recruited peritoneal cells were isolated from WT and STAT6−/− mice, and TREM-2 expression was assayed by FACS. TREM-2 is expressed independently of STAT6 expression.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Generation of TREM-2−/− mice. A, The TREM-2 genomic locus was deleted by homologous recombination with a construct eliminating portions of exons 3 and 4 (P represents a PST1 restriction site). B, Macrophages were derived from WT or TREM2−/− and stained with mAb 178. TREM-2 was well expressed on WT cells but absent on the TREM2−/− cells.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    TREM-2 attenuates macrophage cytokine production. Macrophages were stimulated with the indicated concentration of LPS, zymosan, or CpG, and the levels of TNF-α and IL-6 in the supernatant were measured 24 h later. A, WT vs TREM-2−/− BMDM. TREM-2−/− cells produce increased cytokine as compared with WT cells. ∗, p < 0.05; data are representative of at least three independent experiments. B, TREM-2 accounts for the decreased cytokine response by DAP12−/− cells. WT, TREM-2, and DAP12−/− BMDM were stimulated as indicated. Both WT and DAP12−/− cells produced increased cytokine as compared with WT. There was no difference between TREM-2 and DAP12−/− cells. ∗, p < 0.05; data are representative of at least two independent experiments. C, TREM-2 inhibits the primary macrophage response to LPS. Peritoneal macrophages were isolated from WT or TREM-2−/− mice and stimulated with LPS at the indicated doses for 24 h. TREM-2−/− cells produced increased TNF-α and IL-6 in response to LPS. ∗, p < 0.05.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 177 (6)
The Journal of Immunology
Vol. 177, Issue 6
15 Sep 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: TREM-2 Attenuates Macrophage Activation
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Isaiah R. Turnbull, Susan Gilfillan, Marina Cella, Taiki Aoshi, Mark Miller, Laura Piccio, Maristela Hernandez, Marco Colonna
The Journal of Immunology September 15, 2006, 177 (6) 3520-3524; DOI: 10.4049/jimmunol.177.6.3520

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Isaiah R. Turnbull, Susan Gilfillan, Marina Cella, Taiki Aoshi, Mark Miller, Laura Piccio, Maristela Hernandez, Marco Colonna
The Journal of Immunology September 15, 2006, 177 (6) 3520-3524; DOI: 10.4049/jimmunol.177.6.3520
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: Hypoxia-Induced Ubc9 Promoter Hypermethylation Regulates IL-17 Expression in Ulcerative Colitis
  • Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses
  • Cutting Edge: Heterogeneity in Cell Age Contributes to Functional Diversity of NK Cells
Show more Cutting Edge

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606